Century Therapeutics, Inc.
IPSC- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001850119
In the last 90 days, Century Therapeutics, Inc. insiders filed 0 open-market purchases and 5 sales; 100 institutions reported holding it in 13F filings for Q2 2026, worth $387.0M in total; no superinvestor holds it.
Q1 2025 vs. Q4 2024
How the institutions holding Century Therapeutics, Inc. changed between Q4 2024 and Q1 2025.
All holders in Q1 2025All holders in Q4 2024
| Measure | Q4 2024 | Of which not filed for Q1 2025 | Q1 2025 | Change |
|---|---|---|---|---|
| Holders | 72 | 1 | 70 | −1 |
| Shares | 36.4M | 157.3K | 29.6M | −6.68M (−18.4%) |
| Value | $36.8M | $158.9K | $14.1M | −$22.5M (−61.6%) |
1 institution that held it in Q4 2024 haven't filed for Q1 2025 yet. Not filing isn't selling, so the changes leave them out.
New holders (7)
Institutions that held Century Therapeutics, Inc. at the end of Q1 2025 but not at the end of Q4 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Nuveen, LLC | 157,311 | $74.9K | 0.00% |
| Ieq Capital, LLC | 22,841 | $10.9K | 0.00% |
| Cerity Partners LLC | 14,260 | $6.79K | 0.00% |
| CIBC World Markets Corp | 10,384 | $4.94K | 0.00% |
| The PNC Financial Services Group, Inc. | 7,027 | $3.35K | 0.00% |
| True Wealth Design, LLC | 55 | $27 | 0.00% |
| EverSource Wealth Advisors, LLC | 41 | $20 | 0.00% |
Sold out (8)
Institutions that held Century Therapeutics, Inc. at the end of Q4 2024 and filed for Q1 2025 without it.
| Institution | Shares, Q4 2024 | Value, Q4 2024 |
|---|---|---|
| Millennium Management LLC | 1,607,174 | $1.62M |
| Index Venture Life Associates VI Ltd | 188,251 | $190.1K |
| Jane Street Group, LLC | 48,036 | $48.5K |
| Marshall Wace, LLP | 35,511 | $35.9K |
| Prudential Financial Inc | 15,150 | $15.3K |
| JustInvest LLC | 10,214 | $10.3K |
| Founders Financial Securities LLC | 10,000 | $10.1K |
| Clear Street LLC | 3,100 | $3.13K |
Not filed for Q1 2025 yet (1)
Institutions that held Century Therapeutics, Inc. at the end of Q4 2024 and haven't filed a 13F for Q1 2025. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q4 2024 | Value, Q4 2024 |
|---|---|---|
| Nuveen Asset Management, LLC | 157,311 | $158.9K |